Sodium phosphate

Drug ingredientActive Shortage

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

Molecular structure of 7632-05-5
US Production226.5K lbs
Import Volume268 lbs
Import Dependency0%

Where It Comes From

EPA-registered manufacturers (1)
Nalco- An Ecolab
4 FDA-registered drug labelers
Hyland's Inc.
Lukare Medical, LLC
PEKANA Naturheilmittel GmbH
Seroyal USA

Why It Matters

Sectors
HealthEnergyMetals & MiningCore Chemicals
Downstream Uses

Appears in 6 drug and cosmetic product listings (FDA).

  • Nerve Tonic Stress Relief
  • Elliotts B
  • Natrium Phosphoricum 6X
  • apo-STOM
  • Ferrum Phosphate
  • Nerve Tonic
FDA Shortage Status
Active Shortage
Shortage History
current

Dexamethasone Sodium Phosphate Injection

02/08/2019

Available

current

Dexamethasone Sodium Phosphate Injection

02/08/2019

Unavailable

Industrial Uses

Used in 3 sectors as 2 functional roles.

  • Intermediate in All Other Chemical Product and Preparation Manufacturing (100%)Processing—incorporation into formulation, mixture, or reaction product
  • Anti-scaling agent in All Other Chemical Product and Preparation Manufacturing (9%)Processing—repackaging
  • Anti-scaling agent in Oil and Gas Drilling, Extraction, and Support activities (45%)Use—non-incorporative activities
  • Anti-scaling agent in Other (2%)Use—non-incorporative activities

Chemical Identity

CAS7632-05-5
PubChem CIDNo data available
DTXSIDDTXSID3037674
FormulaNo data available
Mol. WeightNo data available
SMILESNo data available

Data Sources

DTXSID30376742026-04-06

https://doi.org/10.23645/epacomptox.5588566

Archive: data/sources/comptox/dsstox_identifiers.csv

7632-05-52026-04-24

https://www.epa.gov/chemical-data-reporting

Archive: data/sources/epa_cdr/2020_cdr.csv

CAS 7632-05-52026-06-13

https://api.fda.gov/drug/shortages.json

Archive: data/sources/fda/shortages/shortages.json